iSpecimen Inc. financial data

Symbol
ISPC on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
8 Cabot Road, Suite 1800, Woburn, MA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Apr 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 79.7 % -70.7%
Debt-to-equity 115 % +288%
Return On Equity -239 % -197%
Return On Assets -111 % -79.1%
Operating Margin -93.9 % +7.21%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.5M shares -72.5%
Common Stock, Shares, Outstanding 1.7M shares +274%
Entity Public Float 10.4M USD -20.5%
Common Stock, Value, Issued 170 USD +278%
Weighted Average Number of Shares Outstanding, Basic 711K shares +57.2%
Weighted Average Number of Shares Outstanding, Diluted 687K shares +51.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.4M USD +0.74%
Selling and Marketing Expense 4.95M USD +25%
General and Administrative Expense 6.07M USD +2.23%
Costs and Expenses 22M USD +4.37%
Operating Income (Loss) -12.7M USD -14%
Nonoperating Income (Expense) 230K USD +230%
Net Income (Loss) Attributable to Parent -12.5M USD -12.6%
Earnings Per Share, Basic -17.6 USD/shares +28.4%
Earnings Per Share, Diluted -2.1 USD/shares +54.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.88M USD -19.9%
Marketable Securities, Current 6.21M USD
Cash, Cash Equivalents, and Short-term Investments 1.75M USD -69.1%
Accounts Receivable, after Allowance for Credit Loss, Current 1.44M USD +98.3%
Assets, Current 3.59M USD -56.5%
Property, Plant and Equipment, Net 93.6K USD -26.8%
Operating Lease, Right-of-Use Asset 328K USD +69.2%
Other Assets, Noncurrent 213K USD
Assets 9.35M USD -40.9%
Accounts Payable, Current 4.2M USD +6.93%
Accrued Liabilities, Current 1.17M USD -24.1%
Contract with Customer, Liability, Current 361K USD -13.2%
Liabilities, Current 5.77M USD -4.6%
Operating Lease, Liability, Noncurrent 269K USD +823%
Liabilities 6.04M USD -0.64%
Accumulated Other Comprehensive Income (Loss), Net of Tax 41 USD -99.8%
Retained Earnings (Accumulated Deficit) -71.9M USD -21.1%
Stockholders' Equity Attributable to Parent 3.31M USD -66%
Liabilities and Equity 9.35M USD -40.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.07M USD +26.7%
Net Cash Provided by (Used in) Financing Activities -119K USD -275%
Net Cash Provided by (Used in) Investing Activities 1.94M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 1.7M shares +273%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.88M USD -19.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.47K USD +26.3%
Deferred Tax Assets, Valuation Allowance 18.2M USD +20.1%
Deferred Tax Assets, Gross 18.4M USD +19.3%
Operating Lease, Liability 312K USD +59.1%
Depreciation 65.7K USD -44.1%
Payments to Acquire Property, Plant, and Equipment 9.14K USD +13.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.5M USD -12.6%
Lessee, Operating Lease, Liability, to be Paid 381K USD +87.1%
Property, Plant and Equipment, Gross 436K USD -23.9%
Operating Lease, Liability, Current 43.4K USD -74%
Lessee, Operating Lease, Liability, to be Paid, Year Two 76.4K USD -56.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 66.7K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +33.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 68.9K USD +826%
Lessee, Operating Lease, Liability, to be Paid, Year Three 80.2K USD +173%
Deferred Tax Assets, Operating Loss Carryforwards 15.4M USD +21.8%
Preferred Stock, Shares Authorized 50M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 158K USD
Additional Paid in Capital 75.2M USD +8.78%
Amortization of Intangible Assets 47.9K USD
Share-based Payment Arrangement, Expense 18.1K USD -40.8%
Interest Expense 20.8K USD -81.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares